Patent US3475310A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4096091A Expired / Lapsed US ⏱️ 0.0 years remaining

Limulus lysate having improved capacity to precipitate in the presence of low endotoxin concentrations, and reconstituting solutions therefor

Assignee: Baxter International Inc
•
Filing: 1974-07-17
•
Granted: 1978-06-20
•
Expires: 1994-07-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A family of catalysts is disclosed for providing improved capacity for Limulus lysate solution to precipitate in the presence of extremely low concentrations of endotoxin. The catalyst family includes imidazole, manganese ions, Cleland's reagent, magnesium ions, strontium ions, barium ions, cysteine, lithium ions, and various combinations of the above materials. Solutions of the above catalysts may be used to advantage to reconstitute lyophilized Limulus lysate.

Inventors

  • 👤 II Robert E. Hopkins

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 02:39
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/579

Claims Analysis

Total Claims: 56
Claim 1
Independent Claim 50 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of a material selected from the group consisting of imidazole, ionic manganese, Cleland's reagent, glutathione, alkali metal thioglycollates, thiouracil, and cysteine.
Claim 2
Dependent Claim 50 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of a material selected from the group consisting of imidazole, ionic manganese, Cleland's reagent, glutathione, alkali metal thioglycollates, thiouracil, and cysteine.
Claim 3
Dependent Claim 31 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of imidazole.
Claim 4
Dependent Claim 31 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of imidazole.
Claim 5
Dependent Claim 34 words
The Limulus lysate solution of claim 2 having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said lysate solution containing from 0.004 to 0.4 mole of imidazole per liter.
Claim 6
Dependent Claim 20 words
The solution of claim 3 in which from 0.01 to 0.3 mole of imidazole are present per liter of solution.
Claim 7
Dependent Claim 22 words
The solution of claim 3 in which from 0.005 to 0.3 mole of Li + ions are present per liter of solution.
Claim 8
Dependent Claim 22 words
The solution of claim 4 in which from 0.02 to 0.15 mole of Li + ions are present per liter of solution.
Claim 9
Dependent Claim 22 words
The solution of claim 3 in which from 0.005 to 0.3 mole of Mg ++ ions are present per liter of solution.
Claim 10
Dependent Claim 22 words
The solution of claim 4 in which from 0.01 to 0.1 mole of Mg ++ ions are present per liter of solution.
Claim 11
Dependent Claim 22 words
The solution of claim 3 in which from 0.0005 to 0.008 mole of [thioglycollate] - ions are present per liter of solution.
Claim 12
Dependent Claim 21 words
The solution of claim 9 in which said thioglycollate ions are added to said solution in the form of sodium thioglycollate.
Claim 13
Dependent Claim 22 words
The solution of claim 3 in which from 0.005 to 0.3 mole of Sr ++ ions are present per liter of solution.
Claim 14
Dependent Claim 22 words
The solution of claim 4 in which from 0.02 to 0.15 mole of Sr ++ ions are present per liter of solution.
Claim 15
Dependent Claim 22 words
The solution of claim 8 in which from 0.0005 to 0.008 mole of [thioglycollate] - ions are present per liter of solution.
Claim 16
Dependent Claim 37 words
The solution of claim 13 in which from 0.02 to 0.03 mole of Mg ++ ions; 0.02 to 0.03 mole of imidazole; and 0.001 to 0.002 mole of [thioglycollate] - ions are present per liter of solution.
Claim 17
Dependent Claim 19 words
The solution of claim 14 in which the Mg ++ ions are added in the form of magnesium chloride.
Claim 18
Dependent Claim 19 words
The solution of claim 15 in which said [thioglycollate] - ions are added in the form of sodium thioglycollate.
Claim 19
Dependent Claim 22 words
The solution of claim 3 in which from 0.01 to 0.2 mole of Li + ions are present per liter of solution.
Claim 20
Dependent Claim 19 words
The solution of claim 17 in which said Li + ions are added in the form of lithium chloride.
Claim 21
Dependent Claim 32 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of ionic manganese.
Claim 22
Dependent Claim 32 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of ionic manganese.
Claim 23
Dependent Claim 35 words
The Limulus lysate solution of claim 19 having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said lysate solution containing from 0.005 to 0.1 mole of ionic manganese per liter.
Claim 24
Dependent Claim 20 words
The solution of claim 20 in which from 0.01 to 0.04 mole of Mn ++ ions are present per liter.
Claim 25
Dependent Claim 19 words
The solution of claim 21 in which said Mn ++ ions are added in the form of manganese chloride.
Claim 26
Dependent Claim 32 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of Cleland's reagent.
Claim 27
Dependent Claim 32 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of Cleland's reagent.
Claim 28
Dependent Claim 37 words
The Limulus lysate solution of claim 23 having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said lysate solution containing from 0.00005 to 0.0005 mole of Cleland's reagent per liter of solution.
Claim 29
Dependent Claim 21 words
The solution of claim 24 in which from 0.0001 to 0.0003 mole of Cleland's reagent are present per liter of solution.
Claim 30
Dependent Claim 47 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of an organic sulfhydryl-containing compound selected from the group consisting of cysteine, glutathione, alkali metal thioglycollates, and thiouracil.
Claim 31
Dependent Claim 47 words
In a Limulus lysate solution, for providing improved capacity for the solution to precipitate in the presence of extremely low concentrations of endotoxin, the improvement comprising a catalytic concentration of an organic sulfhydryl-containing compound selected from the group consisting of cysteine, glutathione, alkali metal thioglycollates, and thiouracil.
Claim 32
Dependent Claim 34 words
The Limulus lysate solution of claim 26 having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said lysate solution containing from 0.005 to 0.03 mole of cysteine per liter.
Claim 33
Dependent Claim 25 words
The solution of claim 27 in which said cysteine is added in the form of cysteine hydrochloride neutralized to generally neutral pH with an alkali.
Claim 34
Dependent Claim 14 words
The solution of claim 26 which also contains a catalytic amount of magnesium ions.
Claim 35
Dependent Claim 60 words
A Limulus lysate solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said lysate solution containing from 0.2 to 2 percent by weight of water-soluble magnesium salt and from 0.02 to 0.2 percent by weight of an organic sulfhydryl-containing compound selected from the group consisting of cysteine, alkali metal thioglycollate salts, and 2-thioamino uracil.
Claim 36
Dependent Claim 60 words
A Limulus lysate solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said lysate solution containing from 0.2 to 2 percent by weight of water-soluble magnesium salt and from 0.02 to 0.2 percent by weight of an organic sulfhydryl-containing compound selected from the group consisting of cysteine, alkali metal thioglycollate salts, and 2-thioamino uracil.
Claim 37
Dependent Claim 13 words
The solution of claim 30 in which said magnesium salt is magnesium chloride.
Claim 38
Dependent Claim 13 words
The solution of claim 31 in which said sulfhydryl-containing compound is sodium thioglycollate.
Claim 39
Dependent Claim 52 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to produce a solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution containing from 0.004 to 0.4 mole of imidazole, and from 0.005 to 0.3 mole of Mg ++ ions per liter of solution.
Claim 40
Dependent Claim 52 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to produce a solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution containing from 0.004 to 0.4 mole of imidazole, and from 0.005 to 0.3 mole of Mg ++ ions per liter of solution.
Claim 41
Dependent Claim 30 words
The reconstituting solution of claim 33 in which from 0.01 to 0.3 mole of imidazole and 0.01 to 0.1 mole of Mg ++ ions are present per liter of solution.
Claim 42
Dependent Claim 23 words
The reconstituting solution of claim 34 in which from 0.0001 to 0.008 mole of [thioglycollate] - ions are present per liter of solution.
Claim 43
Dependent Claim 22 words
The solution of claim 35 in which from 0.2 to 0.15 mole of Li + ions are present per liter of solution.
Claim 44
Dependent Claim 48 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to produce a solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution containing from 0.004 to 0.4 mole of imidazole, and from 0.005 to 0.3 mole of Sr ++ ions.
Claim 45
Dependent Claim 48 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to produce a solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution containing from 0.004 to 0.4 mole of imidazole, and from 0.005 to 0.3 mole of Sr ++ ions.
Claim 46
Dependent Claim 30 words
The solution of claim 37 in which from 0.01 to 0.3 mole of imidazole, and from 0.02 to 0.15 mole of Sr ++ ions are present per liter of solution.
Claim 47
Dependent Claim 69 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to provide a Limulus solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution comprising from 0.2 to 2 percent by weight of water-soluble magnesium salt and from 0.02 to 0.2 percent by weight of a sulfhydryl-containing compound selected from the group consisting of cysteine, alkali metal thioglycollate salts, and 2-thio-amino uracil.
Claim 48
Dependent Claim 69 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to provide a Limulus solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution comprising from 0.2 to 2 percent by weight of water-soluble magnesium salt and from 0.02 to 0.2 percent by weight of a sulfhydryl-containing compound selected from the group consisting of cysteine, alkali metal thioglycollate salts, and 2-thio-amino uracil.
Claim 49
Dependent Claim 13 words
The solution of claim 39 in which said magnesium salt is magnesium chloride.
Claim 50
Dependent Claim 27 words
The solution of claim 40 in which about 0.5 weight percent of magnesium chloride is present, and about 0.05 weight percent of said sulfhydryl-containing compound is present.
Claim 51
Dependent Claim 13 words
The solution of claim 41 in which said sulfhydryl-containing compound is sodium thioglycollate.
Claim 52
Dependent Claim 12 words
The solution of claim 41 in which said sulfhydryl-containing compound is cysteine.
Claim 53
Dependent Claim 50 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to provide a solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution containing from 0.004 to 0.4 mole of imidazole and from 0.005 to 0.3 mole of Li + ions per liter.
Claim 54
Dependent Claim 50 words
An endotoxin-free water solution for reconstituting lyophilized Limulus lysate to provide a solution having improved capacity to precipitate in the presence of extremely low concentrations of endotoxin, said reconstituting solution containing from 0.004 to 0.4 mole of imidazole and from 0.005 to 0.3 mole of Li + ions per liter.
Claim 55
Dependent Claim 21 words
The solution of claim 44 in which from 0.03 to 0.15 mole of lithium chloride are present per liter of solution.
Claim 56
Dependent Claim 26 words
The solution of claim 32 in which about 0.5 percent by weight of magnesium chloride and about 0.05 percent by weight of sodium thioglycollate is present.

References Cited (Backward Citations)

US3954663A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-06-19 1981-12-19 1982-06-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-06-19 1985-12-19 1986-06-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-06-19 1989-12-19 1990-06-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag